"Stago’s first mission is to provide health professionals with reliable, powerful and innovative haemostasis diag- nostic tools in looking for a way to improve prevention, understanding, diagnostic, treatment and follow-up of coagulation-related patholo- gies. The values set by Stago from its beginning, have led it to be referred to as the leader in the field of haemostasis and thrombosis.

As a result of a spirit of innovation and corporate strategy developed by our company among the staff, on an ethical and independent basis, we are today in a position to bring powerful diagnosis solutions to provide a major contribution to patient's care.

Stago commits itself daily to respond effectively to the needs of biologists all over the world by offering a wide range of products and services, resulting from its ground-breaking skills and know-how in the design of haemostasis systems (reagents, instruments and accessories).

Thanks to a wide network of distributors and subsidiaries in over 110 countries, we are in a position to ensure an efficient customer service and to develop a customized offer, taking into account the market expectations and the different health systems. Today, 85% of the production formulated and manufactured in France is marketed worldwide.

The field of biology is broadening and developing. As a result of the advancements in genetics and human physiology, the medicine is going to evolve into individualized treatments in need of diagnostic markers and personalized follow-up. These are tomorrow’s challenges.

Relying on its own firm history and on human and technological resources, Stago still has a good story to write..."

 
Lionel VIRET
President